课题基金 / 基金详情

Developing high beta-glucan barley as a sustainable healthy wholegrain food

Developing high beta-glucan barley as a sustainable healthy wholegrain food
开发高β-葡聚糖大麦作为可持续的健康全麦食品
批准号:
2882719
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Spring barley plays an important role in sustainable rotations, requiring lower inputs of nitrogen fertilizer, herbicides, fungicides and plant growth regulators than winter wheat and facilitates either over-winter stubbles for wildlife or use of cover crops. In recent years there has been an increase in the spring barley area in England, mainly to help control black-grass, a predominately autumn-germinating weed. The UK produces over 7m tonnes of barley each year, predominantly for use in animal feed, brewing, distilling and export. The food industry uses little barley even though barley can deliver equivalent health benefits to oats. These are largely due to inherently high levels of beta-glucan: a non-starch, non-cellulosic polysaccharide which is found in the cell walls of cereal grains. This remains undigested in the human small intestine, acting as a soluble fibre which confers significant dietary health benefits, through actively lowering blood cholesterol and slowing post-prandial glucose release. New food markets for barley would increase economic and social sustainability by providing farmers with higher value markets for an established crop, and by improving population health by reducing risk of type-2 diabetes and cardio-vascular disease. Our project aims to support the development of healthier wholegrain barley as a food ingredient, by increasing our understanding of the genetic and environmental factors that can impact on beta-glucan levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
人附睾蛋白4靶向调控TGF beta-smad轴加剧克罗恩病相关肠纤维化进程的作用机制研究
AP2B通过WNT/BETA-CATENIN调控颅骨元件成骨活性差异的 分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    孙贤杰
  • 依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
  • 批准号:
    82303919
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    陈鹭跃
  • 依托单位: